Evidence map›Paper›PMID 39871105›Full record

ArticleMicrobial biotechnology2025

Engineered Passive Glucose Uptake in Pseudomonas taiwanensis VLB120 Increases Resource Efficiency for Bioproduction.

Tobias Schwanemann, Nicolas Krink, Pablo I Nikel, Benedikt Wynands, Nick Wierckx

Abstract read
In one paragraph

Article in Microbial biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tobias SchwanemannInstitute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID 0000-0002-6045-6793
Nicolas KrinkThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.ORCID 0000-0002-9878-5656
Pablo I NikelThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.ORCID 0000-0002-9313-7481
Benedikt WynandsInstitute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID 0000-0001-8599-3205
Nick WierckxInstitute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, Jülich, Germany.ORCID 0000-0002-1590-1210

Funding

Bundesministerium für Bildung und Forschung FKZ 031B0852ADeutsche Bundesstiftung Umwelt 20019/638-32Deutscher Akademischer Austauschdienst 57556281European Research Council 101044949Novo Nordisk Fonden NNF18OC0034818Novo Nordisk Fonden NNF20CC0035580Novo Nordisk Fonden NNF21OC0067996
6 · The paper itself

Abstract

Glucose is the most abundant monosaccharide and a principal substrate in biotechnological production processes. In Pseudomonas, this sugar is either imported directly into the cytosol or first oxidised to gluconate in the periplasm. While gluconate is taken up via a proton-driven symporter, the import of glucose is mediated by an ABC-type transporter, and hence both require energy. In this study, we heterologously expressed the energy-independent glucose facilitator protein (Glf) from Zymomonas mobilis to replace the native energy-demanding glucose transport systems, thereby increasing the metabolic energy efficiency. The implementation of passive glucose uptake in engineered production strains significantly increased product titres and yields of the two different aromatic products, cinnamic acid (+10%-15%) and resveratrol (+26%; 18.1 mg/g) in batch cultures.

Indexed as

GlucoseMetabolic EngineeringPseudomonasBiological TransportCinnamatesRecombinant ProteinsZymomonasCinnamatescinnamic acidGlucoseRecombinant ProteinsATP consumptionglucose transportmetabolic engineeringPseudomonasstrain optimization

Identifiers

PMID39871105
PMCPMC11772102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.